These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 3684131

  • 1. An assessment of pathologic features and treatment modalities in ovarian tumors of low malignant potential.
    Hopkins MP, Kumar NB, Morley GW.
    Obstet Gynecol; 1987 Dec; 70(6):923-9. PubMed ID: 3684131
    [Abstract] [Full Text] [Related]

  • 2. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG, Gershenson DM, Malpica A, Deavers M.
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [Abstract] [Full Text] [Related]

  • 3. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
    Veras E, Deavers MT, Silva EG, Malpica A.
    Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
    [Abstract] [Full Text] [Related]

  • 4. Gynecological malignancies.
    Schaebler DL, Schilder RJ, Young RC.
    Cancer Chemother Biol Response Modif; 1996 May; 16():564-91. PubMed ID: 8639401
    [Abstract] [Full Text] [Related]

  • 5. The benefits of comprehensive surgical staging in the management of early-stage epithelial ovarian carcinoma.
    Le T, Adolph A, Krepart GV, Lotocki R, Heywood MS.
    Gynecol Oncol; 2002 May; 85(2):351-5. PubMed ID: 11972399
    [Abstract] [Full Text] [Related]

  • 6. Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis.
    Sherman ME, Mink PJ, Curtis R, Cote TR, Brooks S, Hartge P, Devesa S.
    Cancer; 2004 Mar 01; 100(5):1045-52. PubMed ID: 14983501
    [Abstract] [Full Text] [Related]

  • 7. Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion.
    McKenney JK, Balzer BL, Longacre TA.
    Am J Surg Pathol; 2006 Oct 01; 30(10):1209-21. PubMed ID: 17001150
    [Abstract] [Full Text] [Related]

  • 8. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
    Chambers SK, Kacinski BM, Ivins CM, Carcangiu ML.
    Clin Cancer Res; 1997 Jun 01; 3(6):999-1007. PubMed ID: 9815777
    [Abstract] [Full Text] [Related]

  • 9. Epithelial ovarian tumors of low malignant potential.
    Massad LS, Hunter VJ, Szpak CA, Clarke-Pearson DL, Creasman WT.
    Obstet Gynecol; 1991 Dec 01; 78(6):1027-32. PubMed ID: 1945202
    [Abstract] [Full Text] [Related]

  • 10. Mucinous tumor of low malignant potential ("borderline" or "atypical proliferative" tumor) of the ovary: a study of 171 cases with the assessment of intraepithelial carcinoma and microinvasion.
    Khunamornpong S, Settakorn J, Sukpan K, Suprasert P, Siriaunkgul S.
    Int J Gynecol Pathol; 2011 May 01; 30(3):218-30. PubMed ID: 21464732
    [Abstract] [Full Text] [Related]

  • 11. Prognostic importance of intraoperative rupture of malignant ovarian epithelial neoplasms.
    Sainz de la Cuesta R, Goff BA, Fuller AF, Nikrui N, Eichhorn JH, Rice LW.
    Obstet Gynecol; 1994 Jul 01; 84(1):1-7. PubMed ID: 8008300
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Twenty-five year outcome of sequential abdominal radiotherapy and melphalan:implications for future management of epithelial carcinoma of the ovary.
    Dusenbery KE, Bellairs EE, Potish RA, Twiggs LB, Boente MP.
    Gynecol Oncol; 2005 Feb 01; 96(2):307-13. PubMed ID: 15661213
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial.
    Trimbos JB, Vergote I, Bolis G, Vermorken JB, Mangioni C, Madronal C, Franchi M, Tateo S, Zanetta G, Scarfone G, Giurgea L, Timmers P, Coens C, Pecorelli S, EORTC-ACTION collaborators. European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm.
    J Natl Cancer Inst; 2003 Jan 15; 95(2):113-25. PubMed ID: 12529344
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Clinical analysis of 57 patients with ovarian dysgerminoma].
    Li YF, Li MD, Wu QL, Liu FY, Li JD, Zou JL, Huang YW.
    Ai Zheng; 2002 Jan 15; 21(1):79-82. PubMed ID: 12500404
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Retrospective cohort study of surgical staging for ovarian low malignant potential tumors.
    Wingo SN, Knowles LM, Carrick KS, Miller DS, Schorge JO.
    Am J Obstet Gynecol; 2006 May 15; 194(5):e20-2. PubMed ID: 16647891
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.